Form 4 for CELU Celularity Inc
Accepted 2023-06-16 00:00:00 ET · period of report 2023-06-14 · accession 0000899243-23-015876 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-16 | 2023-06-14 | CELU | SCULLEY JOHN | Dir | A - Grant | $0.00 | +199.9K | 1.00M | +25% | $0 |
| D | 2023-06-16 | 2023-06-14 | CELU | SCULLEY JOHN | Dir | A - Grant | $0.00 | +277.8K | 277.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-06-14 | A | A | 199,921 | $0.00 | 1,004,660 | D | — | — | (F1) These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, June 14, 2023, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date. (F2) Includes 199,921 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, June 14, 2023, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-06-14 | A | A | 277,778 | $0.00 | 277,778 | D | $0.75 · — to 2033-06-14 | 277,778 Class A Common Stock | (F3) This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, June 14, 2023, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date. |